Targeted genome modifications using integrase-deficient lentiviral vectors

Molecular Therapy

Volumn 15, Issue 12, 2007, Pages 2107-2113

  Cornu, Tatjana I ^a   Cathomen, Toni ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; ENHANCED GREEN FLUORESCENT PROTEIN; INTEGRASE; LENTIVIRUS VECTOR; NUCLEASE;

ARTICLE; CELL TYPE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA MODIFICATION; DNA REPAIR; DNA STRAND BREAKAGE; DNA TEMPLATE; ENZYME DEFICIENCY; EXPRESSION VECTOR; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENE TRANSFER; GENOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; NONHUMAN; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM;

EID: 36349019180     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300345     Document Type: Article

References (50)

1. Aiuti, A, Slavin, S, Aker, M, Ficara, F, Deola, S, Mortellaro A et al. (2002). Correction of ADA-SCID by stem A gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
2. Hacein-Bey-Abina, S, Le Deist, F, Carlier, F, Bouneaud, C, Hue, C, De Villartay, JP et al. (2002). Sustained correction of X-rinked severe combined immunodeficiency by ex vivo gene therapy. N Engl Med 346: 1185-1193.
3. Gaspar, HB, Parsley, KL, Howe, S, King, D, Gilmour, KC, Sinclair, J et al. (2004). Gene therapy of X-linked-severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187.
4. Ott, MG, Schmidt, M, Schwarzwaelder, K, Stein, S, Siler, U, Koehl, U et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
5. Rouet, P, Smih, F and Jasin, M (1994). Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci USA 91: 6064-6068.
6. Choulika, A, Perrin, A, Dujon, B and Nicolas, JF (1995). Induction of homologous recombination in mammalian chromosomes by using the l-Scel system of Saccharomyces cerevisiae. Mol Cell Biol 15: 1968-1973.
7. Smih, F, Rouet, P, Romanienko, PJ and Jasin, M (1995). Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cells. Nucleic Acids Res 23: 5012-5019.
8. Porteus, MH and Carroll, D (2005). Gene targeting using zinc finger nucleases. Not Biotechnol 23: 967-973.
9. Russell, DW and Hirata, RK (1998). Human gene targeting by viral vectors. Nat Genet 18: 325-330.
10. Miller, DG, Petek, LM and Russell, DW (2003). Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol Cell Biol 23: 3550-3557.
11. Porteus, MH, Cathomen, T, Weitzman, MD and Baltimore, D (2003). Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol Cell Biol 23: 3558-3565.
12. Srivastava, A (2005). Hematopoietic stem cell transduction by recombinant adeno-associated virus vectors: Problems and solutions. Hum Gene Ther 16: 792-798.
13. Baum, C, Schambach, A, Bohne, J and Galla, M (2006). Retrovirus vectors: toward the plentivirus? Mol Ther 13: 1050-1063.
14. Ells, J and Bernstein, A (1989). Gene targeting with retroviral vectors: recombination by gene conversion into regions of nonhomology. Mol Cell Biol 9: 1621-1627.
15. Loewen, N, Leske, DA, Chen, Y, Teo, WL, Saenz, DT, Peretz, M et al. (2003). Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J Gene Med 5: 1009-1017.
16. Brussel, A and Sonigo, P (2004). Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species. J Virol 78: 11263-11271.
17. Saenz, DT, Loewen, N, Peretz, M, Whitwam, T, Barraza, R, Howell, KG et al. (2004). Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: Analysis with class I integrase mutants. J Virol 78: 2906-2920.
18. Vargas, J, Jr, Gusella, GL, Najfeld, V, Klotman, ME and Cara, A (2004). Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther 15: 361-372.
19. Philippe, S, Sarkis, C, Barkats, M, Mammeri, H, Ladroue, C, Petit, C et al. (2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 103: 17684-17689.
20. Yanez-Munoz, RJ, Balaggan, KS, MacNeil, A, Howe, SJ, Schmidt, M, Smith, AJ et al. (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12: 348-353.
21. Philpott NJ and Thrasher, AJ (2007). Use of nonintegrating lentiviral vectors for gene therapy. Hum Gene Ther 18: 483-489.
22. Engelman, A, Englund, G, Orenstein, JM, Martin, MA and Craigie, R (1995). Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 69: 2729-2736.
23. Zheng, R, Jenkins, TM and Craigie, R (1996). Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci USA 93: 13659-13664.
24. Leavitt, AD, Robles, G, Alesandro, N and Varmus, HE (1996). Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721-728.
25. Engelman, A, Liu, Y, Chen, H, Farzan, M and Dyda, F (1997). Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. J Viral 71: 3507-3514.
26. Lutzke, RA, Vink, C and Plasterk, RH (1994). Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res 22: 4125-4131.
27. Cereseto, A, Manganaro, L, Gutierrez, MI, Terreni, M, Fittipaldi, A, Lusic, M et al. (2005). Acetylation of HFV-1 integrase by p300 regulates viral integration. EMBO J 24: 3070-3081.
28. Alwin, S, Gere, MB, Guhl, E, Effertz, K, Barbas, CF, 3rd, Segal, DJ et al. (2005). Custom zinc-finger nucleases for use in human cells. Mol Ther 12: 610-617.
29. Miller, DG, Petek, LM and Russell, DW (2004). Adeno-associated virus vectors integrate at chromosome breakage sites. Nat Genet 36 767-773.
30. Hendrie, PC and Russell, DW (2005). Gene targeting with viral vectors. Mol Ther 12: 9-17.
31. Fujita, A, Sakagami, K, Kanegae, Y, Saito, I and Kobayashi, I (1995). Gene targeting with a replication-defective adenovirus vector. J Virol 69: 6180-6190.
32. Mitani, K, Wakamiya, M, Hasty, P, Graham, FL, Bradley, A and Caskey, CT (1995). Gene targeting in mouse embryonic stem cells with an adenoviral vector. Somat Cell Mol Genet 21: 221-231.
33. Ohbayashi, F, Balamotis, MA, Kishimoto, A, Aizawa, E, Diaz, A, Hasty, P et al. (2005). Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc Natl Acad Sci USA 102: 13628-13633.
34. Weitzman, MD (2005). Functions of the adenovirus E4 proteins and their impact on viral vectors. Front Biosci 10: 1106-1117.
35. Inoue, N, Hirata, RK and Russell, DW (1999). High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J Virol 73: 7376-7380.
36. Liu, X, Yan, Z, Luo, M, Zak R, Li, Z, Driskell, RR et al. (2004). Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions. J Virol 78: 4165-4175.
37. Miller, DG, Wang, PR, Petek, LM, Hirata, RK, Sands, MS and Russell, DW (2006). Gene targeting in vivo by adeno-associated virus vectors. Nat Biotechnol 24: 1022-1026.
38. Johnson, RD and Jasin, M (2001). Double-strand-break-induced homologous recombination in mammalian cells. Biochem Soc Trans 29: 196-201. ~
39. Baum, C, Kustikova, O, Modlich, U, Li, Z and Fehse, B (2006). Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17:253-263.
40. Nightingale, SJ, Hollis, RP, Pepper, KA, Petersen, D, Yu, XJ, Yang, C et al. (2006). Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13: 1121-1132.
41. Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D et al (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
42. Zufferey, R, Dull, T, Mandel, RJ, Bukovsky, A, Quiroz, D, Naldini, L et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880.
43. Modlich, U, Bohne, J, Schmidt M, von Kalle, C, Knoss, S, Schambach, A et al. (2006). Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 108: 2545-2553.
44. Montini, E, Cesana, D, Schmidt, M, Sanvito, F, Ponzoni, M, Bartholomae, C et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24:687-696.
45. Porteus, MH and Baltimore, D (2003). Chimeric nucleases stimulate gene targeting in human cells. Science 300: 763.
46. Umov, ID, Miller, JC, Lee, YL, Beausejour, CM, Rock JM, Augustus, S et al. (2005). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435: 646-651.
47. Miller, JC, Holmes, MC, Wang, J, Guschin, DY, Lee, YL, Rupniewski, I et al. (2007). An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25: 778-785.
48. Szczepek M, Brondani, V, Buchel, J, Serrano, L, Segal, DJ and Cathomen, T (2007). Structure-based redesign of the climerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 25: 786-793.
49. Radecke, F, Peter, I, Radecke, S, Gellhaus, K, Schwarz, K and Cathomen, T (2006). Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break. Mol Ther 14: 798-808.
50. Cathomen, T, Collete, and Weitzman, MD (2000). A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay. J Virol 74: 2372-2382.